OAKTREE CAPITAL MANAGEMENT LP

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 949509 LOS ANGELES, CA

Back to INDV Full portfolio

Position in INDV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$251,399,508

+$38,524,080 QoQ

Shares Held

6,127,212

-12.3% QoQ

Ownership

5.19%

of shares outstanding

% of Portfolio

6.65%

of 13F equity value

Holder Rank

of 337 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in INDV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

OAKTREE CAPITAL MANAGEMENT LP holds $253,707,210 across 3 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (99.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc. This page	6,127,212	$251,399,508
2	BTAI	BioXcel Therapeutics, Inc.	1,380,248	$1,946,149
3	ALVO	Alvotech	4,764,649	$361,553

All Filings in INDV

Export CSV

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$251,399,508	6,127,212	-12.3%	Shares	Defined	2026-08-14
2026-03-31	$212,875,428	6,984,102	—	Shares	Defined	2026-05-20
No filing history on record for this holder in this stock.